Borosil Scientific Board Meeting Scheduled for May 20, 2026 to Approve FY26 Results and Fund-Raising Resolution

1 min read     Updated on 13 May 2026, 10:41 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Borosil Scientific Limited has scheduled a Board of Directors meeting for May 20, 2026, to approve audited financial results for the quarter and financial year ended March 31, 2026 (Standalone & Consolidated). The board will also consider an enabling resolution for shareholders' approval to raise funds through modes including Qualified Institutional Placement, Further Public Offer, and Foreign Currency Convertible Bonds. A fresh shareholder approval is being sought as the earlier approval obtained at the AGM held on August 11, 2025, carries a validity of 365 days under certain SEBI Regulations. The Trading Window for designated persons has been closed since April 1, 2026, and will remain shut until 48 hours post the results declaration.

powered bylight_fuzz_icon
40237884

*this image is generated using AI for illustrative purposes only.

Borosil Scientific Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Wednesday, May 20, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 13, 2026, and signed by Sanjay Gupta, Company Secretary & Compliance Officer (ICSI Membership No.: A24641).

Key Agenda Items for the Board Meeting

The board meeting has been convened to address two primary matters. The following table summarises the key agenda items:

Agenda Item: Details
Financial Results: Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026
Fund-Raising Resolution: Enabling resolution for shareholders' approval to raise funds through various modes

Fund-Raising Modes Under Consideration

The board will seek shareholders' approval through an enabling resolution for raising funds via multiple avenues, subject to applicable regulatory and statutory approvals. The modes being considered include:

  • Qualified Institutional Placement (QIP)
  • Further Public Offer (FPO)
  • Issuance of Foreign Currency Convertible Bonds (FCCBs)
  • Any other method or a combination thereof, as permitted under applicable laws

Context for Fresh Shareholder Approval

Borosil Scientific noted that a similar approval was obtained from shareholders at the Annual General Meeting (AGM) held on August 11, 2025. Under certain SEBI Regulations, such approval carries a validity of 365 days from the date of approval. In view of this, the company has proposed seeking a fresh approval from shareholders on similar lines at the ensuing AGM, which would provide the company the flexibility to raise funds as and when needed using the most suitable mode.

Trading Window Closure

In connection with the upcoming declaration of financial results, the Trading Window for dealing in the equity shares of the company for all Designated Persons and their immediate relatives was closed from April 1, 2026. The window will remain closed until 48 hours after the declaration of the aforesaid results, in line with applicable SEBI regulations.

The intimation has been made available on the company's website at https://www.borosilscientific.com/ .

Historical Stock Returns for BOROSCI

1 Day5 Days1 Month6 Months1 Year5 Years
+0.27%-4.07%+4.23%-4.52%-12.09%-24.42%

How might Borosil Scientific's choice between QIP, FPO, or FCCBs impact its existing shareholders' equity dilution and stock price performance post-fund raise?

What strategic expansion or capital expenditure plans could Borosil Scientific be targeting with the fresh fund-raising approval, given its position in the scientific glassware sector?

How have peer companies in the laboratory and scientific equipment space utilized similar fund-raising instruments, and what outcomes can Borosil Scientific's investors benchmark against?

Borosil Scientific Limited Promoters Declare NIL Encumbrance on Shares for FY26

1 min read     Updated on 06 May 2026, 05:06 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Borosil Scientific Limited's promoters, led by Pradeep Kumar Kheruka, have declared NIL encumbrance on promoter-held equity shares for the financial year ended March 31, 2026, under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration, dated April 02, 2026, confirms that neither the promoters nor any persons acting in concert created any encumbrance, directly or indirectly, on equity shares during FY26. As on March 31, 2026, NIL equity shares of Borosil Scientific Limited remain encumbered. The filing was submitted to BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited.

powered bylight_fuzz_icon
39569768

*this image is generated using AI for illustrative purposes only.

Borosil Scientific Limited promoters have submitted a formal declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming that no encumbrance was created on any promoter-held equity shares during the financial year ended March 31, 2026. The declaration was filed by Pradeep Kumar Kheruka on behalf of himself and all other promoters and persons acting in concert (PAC). The filing was addressed to BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited.

Key Declaration Highlights

The declaration confirms that the promoters, along with persons acting in concert, have not made any encumbrance, directly or indirectly, on the equity shares held by them in Borosil Scientific Limited during the financial year ended March 31, 2026. As on March 31, 2026, NIL equity shares of Borosil Scientific Limited are encumbered by the promoters or PAC.

Parameter: Details
Regulation: Regulation 31(4), SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Financial Year: Ended March 31, 2026
Encumbrance During FY26: NIL
Encumbered Shares as on March 31, 2026: NIL
Filed By: Pradeep Kumar Kheruka (Promoter)
Date of Filing: April 02, 2026

Persons Acting in Concert

The declaration covers the following promoters and persons acting in concert (PAC) of Borosil Scientific Limited:

  • Kiran Kheruka
  • Rekha Kheruka
  • Pradeep Kumar Kheruka
  • Shreevar Kheruka
  • Gujarat Fusion Glass LLP
  • Spartan Trade Holdings LLP
  • Borosil Holdings LLP
  • Associated Fabricators LLP
  • Sonargaon Properties LLP
  • Croton Trading Private Limited
  • Alaknanda Ruia

Regulatory Compliance

This declaration is a mandatory annual compliance requirement under SEBI's Takeover Regulations, obligating promoters to confirm the status of encumbrance on their shareholding at the end of each financial year. The filing was submitted to both stock exchanges — BSE Limited and the National Stock Exchange of India Ltd — as well as to the Audit Committee of Borosil Scientific Limited, in accordance with the prescribed regulatory framework.

Historical Stock Returns for BOROSCI

1 Day5 Days1 Month6 Months1 Year5 Years
+0.27%-4.07%+4.23%-4.52%-12.09%-24.42%

How might Borosil Scientific Limited's clean encumbrance record influence institutional investor confidence and potential stake acquisitions in the company going forward?

Could the zero-encumbrance status of promoter shares signal potential plans for capital restructuring or strategic acquisitions by Borosil Scientific Limited in the near future?

How does Borosil Scientific Limited's promoter shareholding stability compare to peers in the scientific glassware and laboratory equipment sector, and what does this mean for competitive positioning?

More News on BOROSCI

1 Year Returns:-12.09%